Vascular and Perivascular Cell Type Vulnerability: BBB Integrity Disruption

Target: CLDN5 Composite Score: 0.470 Price: $0.47 Citation Quality: Pending neurodegeneration Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

✓ All Quality Gates Passed

Quality Report Card click to collapse

Composite: 0.470

Top 81% of 1166 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

C Mech. Plausibility 15% 0.48 Top 84%

C Evidence Strength 15% 0.45 Top 79%

C+ Novelty 12% 0.55 Top 88%

D Feasibility 12% 0.35 Top 86%

C+ Impact 12% 0.50 Top 83%

C Druggability 10% 0.42 Top 76%

C+ Safety Profile 8% 0.55 Top 49%

B Competition 6% 0.60 Top 64%

C Data Availability 5% 0.40 Top 87%

D Reproducibility 5% 0.38 Top 91%

Evidence

3 supporting | 3 opposing

Citation quality: 0%

Debates

1 session B+

Avg quality: 0.75

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

Cell type vulnerability debate in Alzheimer's disease (SEA-AD v4)

Which cell types show the greatest vulnerability in Alzheimer's disease according to the SEA-AD dataset (debate analysis)?

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau)

Score: 0.790 | Target: MAPT

Microglial Disease-Associated States: TREM2-Independent Pathways Driving Neuroinflammation

Score: 0.710 | Target: APOE

Astrocyte Reactivity Heterogeneity with APOE4-Dependent Vulnerability

Score: 0.690 | Target: APOE

Oligodendrocyte Lineage Vulnerability: Early Myelination Disruption with Blocked Differentiation

Score: 0.530 | Target: PDGFRα

Inhibitory Neuron Subtype Loss: Excitation/Inhibition Imbalance Hypothesis

Score: 0.520 | Target: GAD1/GAD2

Tripartite Synapse Cell Type-Nonautonomous Crosstalk: Coordinated Failure

Score: 0.510 | Target: C1Q

→ View full analysis & all 7 hypotheses

Description

Endothelial cells and pericytes show AD-related transcriptional changes affecting blood-brain barrier integrity, including tight junction gene downregulation (CLDN5, OCLN), altered pericyte contractile gene expression, and upregulation of adhesion molecules (VCAM1, ICAM1). However, vascular cell RNA is severely degraded by post-mortem interval, tight junction gene downregulation is a known PMI artifact, and BBB dysfunction is inconsistent across AD patients. Major confounding limits interpretability.

No AI visual card yet

3D Protein Structure (AlphaFold)

Open full viewer

AlphaFold predicted structure available for O00501

View AlphaFold Structure

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

6 citations 6 with PMID Validation: 0% 3 supporting / 3 opposing

✓ For (3)

No supporting evidence

No opposing evidence

(3) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 4CLIN 1GENE 1EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
Pericyte loss demonstrated in AD mouse models	Supporting	MECH	-	-	-	-	PMID:Nelson 2016	-
Vascular dysfunction review documenting BBB change…	Supporting	MECH	-	-	-	-	PMID:29516877	-
SEA-AD vascular cell type transcriptomic data avai…	Supporting	MECH	-	-	-	-	PMID:SEA-AD-2022	-
Endothelial/pericyte RNA highly sensitive to PMI; …	Opposing	MECH	-	-	-	-	PMID:PMI confounds	-
BBB dysfunction not universally observed in AD pat…	Opposing	CLIN	-	-	-	-	PMID:Sweeney 2018	-
CLDN5 genetic variants do not show strong AD risk …	Opposing	GENE	-	-	-	-	PMID:genetic studies	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 3

Pericyte loss demonstrated in AD mouse models

PMID:Nelson 2016

Vascular dysfunction review documenting BBB changes in AD

PMID:29516877

SEA-AD vascular cell type transcriptomic data available

PMID:SEA-AD-2022

✗ Opposing Evidence 3

Endothelial/pericyte RNA highly sensitive to PMI; CLDN5 downregulation is artifact

PMID:PMI confounds

BBB dysfunction not universally observed in AD patients

PMID:Sweeney 2018

CLDN5 genetic variants do not show strong AD risk associations

PMID:genetic studies

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-22 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Cell Type Vulnerability in Alzheimer's Disease: SEA-AD v4 Analysis

5-7 Therapeutic/Mechanistic Hypotheses

Hypothesis 1: Excitatory Neuron Subtype-Specific Vulnerability (Layer 2/3 & 5/6)

Title: Layer-specific excitatory neurons show greatest transcriptomic vulnerability in SEA-AD, with mitochondrial dysfunction and synaptic gene downregulation as primary mechanisms

Mechanism: Deep layer excitatory neurons (layer 5-6) and superficial layer 2/3 neurons display the most pronounced AD-related gene expression changes, characterized by:

Downregulation of synaptic transmis

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Critical Evaluation of Cell Type Vulnerability Hypotheses in SEA-AD v4

Methodological Preface

Before evaluating individual hypotheses, several global limitations of the SEA-AD dataset must be acknowledged:

Cross-sectional design: Post-mortem tissue cannot resolve temporal causality—observed transcriptional changes may be primary disease mechanisms or downstream consequences

Survival bias: Severely affected brains may be overrepresented; rapidly degenerated cell types may be depleted from tissue

Agonal state confounds: Hypoxia, acidosis, and medication effects i

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Feasibility Assessment: SEA-AD v4 Cell Type Vulnerability Hypotheses

Executive Summary

Following the Skeptics' downgrade of all hypotheses (range: 0.51–0.65 confidence), I assessed the surviving mechanistic threads through a drug discovery lens. Only Hypotheses 1 (MAPT/tau), 3 (microglialTYROBP), and 5 (APOE) emerge as Phase I-ready within a 5–7 year horizon. Hypotheses 2 (oligodendrocyte) and 7 (complement) have conditional feasibility pending model validation. Hypotheses 4 (inhibitory) and 6 (vascular) face significant translational barriers.

Hypothesis 1: Excitatory Neur

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

{
"ranked_hypotheses": [
{
"title": "Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau)",
"description": "Deep layer (L5/6) and superficial layer (L2/3) excitatory neurons demonstrate the most pronounced transcriptomic vulnerability in SEA-AD, characterized by synaptic gene downregulation (SNAP25, SYT1, SLC17A7), stress response upregulation (HSPA1B, DNAJB1), and mitochondrial dysfunction signatures. MAPT (tau) emerges as the primary upstream driver with established Phase I-ready ASO and antibody modalities. Layer-specific markers (RORB, THEMIS) pr